Two gastric cancer cell lines engineered to over-express miR-19a or miR-19b, and displaying lower levels of Mxd1 as a consequence, demonstrated enhanced in vitro migration and invasion, whereas these behaviors were impaired when endogenous miR-19a/b were inhibited and normal Mxd1 levels were restored. Here, MXD1 is linked to gastric cancer.